Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Albireo Pharma, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 99 | 94 | −5 |
| Shares | 15.6M | 15.3M | −289.7K (−1.9%) |
| Value | $546.1M | $477.0M | −$69.2M (−12.7%) |
New holders (4)
Institutions that held Albireo Pharma, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 15,136 | $472.0K | 0.00% |
| Gsa Capital Partners LLP | 11,973 | $374.0K | 0.04% |
| SG Americas Securities, LLC | 7,339 | $229.0K | 0.00% |
| Cutler Group LP | 100 | $3.00K | 0.00% |
Sold out (9)
Institutions that held Albireo Pharma, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Farallon Capital Management, L.L.C. | 250,000 | $8.79M |
| DekaBank Deutsche Girozentrale | 33,900 | $1.19M |
| Victory Capital Management Inc | 32,270 | $1.14M |
| Virtu Financial LLC | 14,969 | $527.0K |
| HRT Financial LP | 7,236 | $254.0K |
| ExodusPoint Capital Management, LP | 6,534 | $230.0K |
| First Republic Investment Management, Inc. | 5,940 | $209.0K |
| BerganKDV Wealth Management, LLC | 300 | $11.0K |
| Two Sigma Investments, LP | 54,292 | – |